Celltrion Healthcare has signed agreements with nine European countries for the distribution of Regkirona, Korea's first Covid-19 treatment.
Regkirona, Korea’s first Covid-19 treatment, won conditional use approval from regulators in Peru, Celltrion said Monday.
Regkirona, Korea’s first Covid-19 treatment, won marketing approval from the European Commission, Celltrion said Monday.
Samsung Biologics signed a contract development and manufacturing organization (CDMO) deal with Texas-based Enzolytics for two drugs, including a Covid-19 treatment candidate, the Korean biopharmaceutical company said Thursday.
When swine flu hit the world in 2009, Tamiflu was there to save millions of lives. While Covid-19 has focused attention on development of vaccines, health professionals believe treatments could be almost just as important, especially oral treatments.
GeneOne Life Science’s Covid-19 oral treatment candidate GLS-1027 won approval to start Phase 2 clinical trials in Korea, the company said Thursday.
Celltrion’s Regkirona Covid-19 treatment has received an emergency use authorization (EUA) from regulators in Brazil.
Celltrion’s Regkirona Covid-19 treatment has received an emergency use authorization from regulators in Indonesia.
Celltrion said Friday that animal tests of its Regkirona Covid-19 treatment have produced meaningful results confirming its effectiveness against the Delta variant.
Korea is fast running out of available hospital beds, and Kim Byung-geun, the director of the Bagae General Hospital in Pyeongtaek, Gyeonggi, has offered up his whole hospital for treating coronavirus patients.